[{"Assets_0_Q2_USD":274144000.0,"CommonStockSharesOutstanding_0_Q2_shares":46883000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-124789000.0,"NetIncomeLoss_1_Q2_USD":-74328000.0,"NetIncomeLoss_2_Q2_USD":-140585000.0,"StockholdersEquity_0_Q2_USD":232279000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]